We are on the precipice of Precision Medicine in neurodegenerative diseases (NDDs)
Special thanks to Efe Alyanak, Thomas Angiulo, Puja Ghelani, Alli Gitnik, Hayden Kickbush, Jeff Stoll, Jack Verity
We are on the precipice of precision medicine in neurodegenerative diseases (NDDs) but many key questions remain:
The KPMG Precision Medicine practice is a leader in innovation across all therapeutic areas, in markets around the world. Our comprehensive offerings range from strategic front-end ideation and planning, to commercial, financial, and operational due diligence, and continuing through integration and separation. Our approach is fueled by proprietary clinical and lab data which is unparalleled in the market. Click to see more examples of the transformative work we are doing in strategy, deals and operations for all stakeholders in the Precision Medicine ecosystem.